<DOC>
	<DOCNO>NCT01916304</DOCNO>
	<brief_summary>The purpose study investigate effect switch participant take levothyroxine new sodium formulation .</brief_summary>
	<brief_title>Study Dose Adjustment From Levothyroxine New Levothyroxine Sodium Test Formulation</brief_title>
	<detailed_description>The drug test study new sodium formulation levothyroxine . Levothyroxine ( L-Thyroxine Christiaens® ) use treatment hypothyroidism . This study investigate effect switch subject take levothyroxine new levothyroxine sodium formulation . The result study used provide instruction general practitioner endocrinologist assist patient levothyroxine hormone substitution perform switch new formulation . The study enroll approximately 90 patient . Patients receive daily dose L-Thyroxine Christiaens® past 6 week serum thyroid stimulate hormone ( TSH ) level 0.4-2.5 mU/L switch equivalent daily dose new formulation levothyroxine . After switch , patient follow 2 ( ± 2 week ) 4 month ( ± 4 week ) . All participant ask take daily dose time day throughout study . This study conduct Belgium . Participants make 3 4 visit clinic .</detailed_description>
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>1 . ( Near ) total thyroidectomised patient . 2 . Aged 18 year old . 3 . Stabilised daily dose LThyroxine Christiaens® last 6 week inclusion study . 4 . Written informed consent give . 5 . Able willing comply protocol requirement complete study . 1 . History Graves ' disease positive TSHreceptor antibody . 2 . History thyroid cancer require TSH suppression . 3 . Medical procedure treatment plan could influence thyroid hormone state patient trial . 4 . Use levothyroxine contain medicine provide brand treat hypothyroidism . 5 . Pregnant planning pregnancy . Female patient childbearing potential need apply highly effective method birth control . 6 . Participation another trial past 6 week . 7 . Exclusion criterion study occurrence serious adverse reaction , laboratory clinically relevant change patient status , change smoking status , use drug nonauthorized physician ( avoid relevant drug interaction ) lack patient compliance study drug . ( OR event consider exclusion criterion document case report form , possible explanation change lab parameter and/or dose switch ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>